Organon & Co | OGN - Stock


Organon & Co reported $1.49B in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Celltrion KRW 2.71T 121.94B Jun/2025
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Kangmei Pharma CNY 2.45B 12.27M Sep/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Medical Developments International AUD 9.45M 679K Jun/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Organigram Holdings CAD 132.71M 8.76M Dec/2025
Organon & Co USD 1.49B 34M Sep/2025
Pharma Mar EUR 50.64M 1.13M Dec/2025
Qiagen NV USD 290.23M 2.32M Sep/2025
Sartorius EUR 827.9M 30.5M Sep/2025
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Zealand Pharma A/S 10.7M 9.9M Dec/2024